Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Neximmune - You Need To See This

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine. The initial results from the study are expected during second half of 2023. Gritstone shares traded in a range of $3.96 to $4.24…

The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate

The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

3 Stocks Under $3 Insiders Are Aggressively Buying

3 Stocks Under $3 Insiders Are Aggressively Buying

US crude oil futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours:

Executives Buy More Than $1M Of 5 Penny Stocks

The Dow Jones jumped around 200 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or…

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia

Here's a roundup of top developments in the biotech space over the last 24 hours:

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers NexImmune (NASDAQ:NEXI) stock moved upwards by 8.3% to $3.51 during Monday's after-market session. This security traded at a volume of 109.1K shares come close, making up 76.6% of its average volume over the last 100 days. The company's market cap stands at $80.1 million.

inkl

Read news from The Economist, FT, and more,
with one subscription

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

Insiders Buying These 5 Penny Stocks

Insiders Buying These 5 Penny Stocks

The Dow Jones surged around 350 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or…

4 Penny Stocks Insiders Are Buying

4 Penny Stocks Insiders Are Buying

The Dow Jones surged by more than 250 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall…

Lannett And 4 Other Penny Stocks Bought By Insiders

Lannett And 4 Other Penny Stocks Bought By Insiders

US stock futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or…

NexImmune, Zephyr Join Forces For Oncology Target Discovery, Validation

NexImmune, Zephyr Join Forces For Oncology Target Discovery, Validation

NexImmune Inc (NASDAQ: NEXI) and Zephyr AI have announced a strategic partnership focusing on discovering and validating

1

Organisations

Food and Drug Administration

Gilead Sciences

US Food and Drug Administration

Nature Medicine

Medicines and Healthcare products Regulatory Agency

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

Multiple Sclerosis

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

380,427 stories

140,362 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play